Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a analysis from the adjuvant TOSCA trial

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a analysis from the adjuvant TOSCA trial

Background: The risk of venous thromboembolic events (VTE) during adjuvant chemotherapy for colorectal cancer (CRC) is unknown. We aim to evaluate if the Khorana score (KS) can predict this risk, and if it represents a prognostic factor for overall survival (OS) through a post hoc analysis of the ph...

Full description

Bibliographic Details
Main Authors: Sandro Barni, Gerardo Rosati, Sara Lonardi, Nicoletta Pella, Maria Banzi, Maria G. Zampino, Katia F. Dotti, Lorenza Rimassa, Paolo Marchetti, Evaristo Maiello, Fabrizio Artioli, Daris Ferrari, Roberto Labianca, Paolo Bidoli, Alberto Zaniboni, Alberto Sobrero, Vincenzo Iaffaioli, Sabino De Placido, Gian Luca Frassineti, Andrea Ciarlo, Angela Buonadonna, Nicola Silvestris, Elena Piazza, Lorenzo Pavesi, Mauro Moroni, Mario Clerico, Massimo Aglietta, Paolo Giordani, Francesca Galli, Fabio Galli, Fausto Petrelli
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835919899850

Internet

https://doi.org/10.1177/1758835919899850

Similar Items